Category: biotech

.Though Alkeus Pharmaceuticals’ oral eye illness possession neglected to considerably reduce geographical atrophy (GA) lesion growth, the biotech is citing “clinically meaningful” end results and

.While the biotech assets performance in Europe has actually reduced somewhat observing a COVID-19 funding boom in 2021, a brand-new document from PitchBook suggests equity

.Merck &amp Co. has promptly made back a few of the prices of its Spear Rehabs purchase, drawing in $170 million in advance by including

.Cullinan Rehab was actually made an impression on sufficient with Harbour BioMed’s bispecific invulnerable activator that it handed over $25 million in 2014 for the

.Invite to this week’s Chutes &amp Ladders, our summary of substantial leadership hirings, firings as well as retirings around the sector. Please deliver the praise–

.Compass Pathways’ experience to stage 3 psychedelic depression data is taking a lot longer than expected. With the trials overwhelming by months, the biotech is

.Vertex has actually stated period 3 records on its near-approval ache medication applicant suzetrigine, clarifying just how the non-opioid pain reliever mixes with advil and

.Cognition Therapeutics’ stage 2 sparkle trial has actually taken several of the luster off the Alzheimer’s health condition drug prospect CT1812. The oral sigma-2 villain

.Welcome to today’s Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings and retirings across the business. Satisfy send the praise– or even the

.Mandarin blood insulin maker Gan &amp Lee Pharmaceuticals is actually wading into the obesity world along with an injectable GLP-1 agonist that hammered Novo Nordisk’s